Welsh medical device firm Creo Medical has reported significant revenue increases in its financial results for 2022 following success with its core technology. The Chepstow-based Alternative Investment Market listed firm posted total sales of £27.2m in the 12 months ending December 31 2022.
This was up £2m on the previous year and included first revenues of its Kamaptive licensing programme at £1.4m. Gross profit was also up by 13.3% to £13.1m (2021: £11.6m), with gross margin rising 2.3 percentage points to 48.3%.
Its Speedboat Inject and Croma technologies saw threefold increases in revenue at £900,000 following strong orders and growing sales.
